About Gamma Oryzanol
Gamma Oryzanol is produced from rice bran oil, wheat bran, and some fruits and vegetables. It is known to be a mixture of ferulic acid esters of phytosterols and triterpenoids. It is used as medicine in many conditions like high cholesterol, menopause, etc. Gamma Oryzanol is said to cholesterol levels by reducing the absorption of cholesterol from foods. There is a research gap to support many medical claims of Gamma Oryzanol. Gamma Oryzanol is also used to increase testosterone and growth hormone levels. So, it has increasing use in pharmaceuticals and nutraceuticals. As more health benefits get discovered; the demand is set to increase with it.
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Unit | Value (USD Million) |
Lack of awareness and lack of research about the health benefits of Gamma Oryzanol are the main challenges the industry faces. So, marketing is necessary along with differentiation from competitors. As the product is more or less identical the consumers are expected to buy from the lowest bidders. With increasing demand more and more companies are diversifying their portfolio in this area. Players would have to focus on producers of raw materials to get the best quality and cheap price. Established and emerging Vendors should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Oryza Oil and Fat Chemical (Japan), Gamma Oryzanol (Japan), Henry Lamotte Oils (Germany), Delekang Food (China), Otto Chemie Pvt Ltd (India), Kingcare (India), Huadong Medicine Group (China), FabriChem (United States), Ricela (India) and A.P. Organics Ltd. (India) are some of the key players that are part of study coverage.
Segmentation Overview
AMA Research has segmented the market of Global Gamma Oryzanol market by Type (Pharmaceutical Grade, Food Grade and Others), Application (Cholesterol, Menopause, Acne and Others) and Region.
On the basis of geography, the market of Gamma Oryzanol has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Industry Verticals, the sub-segment i.e. Pharmaceuticals will boost the Gamma Oryzanol market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Sales Channel, the sub-segment i.e. Online will boost the Gamma Oryzanol market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Increasing Consumption of the Oil as It Has High Smoke Point and Growing Demand for Gamma Oryzanol Mainly for Weight Loss
Market Growth Drivers:
Increasing Demand for Gamma Oryzanol to Reduce Cholesterol Levels and Adoption in Athlete’s Diet to Enhance Muscle Growth
Challenges:
Possibility of Unknown Side-Effects Due to Lack of Research and Fluctuation in Raw Material Production Due to Global Warming
Restraints:
Lack of Medical Research to Support and Discover Medical Benefits
Opportunities:
Raising Awareness About Gamma Oryzanol's Benefits and Increase in Consumption of Gamma Oryzanol in North America and Europe
In June 2021, Ricela Group launched gamma oryzanol, a natural antioxidant that helps to reduce high blood cholesterol for the first time in India. Due to the success of gamma oryzanol in India, Ricela is also focusing on the development and manufacturing of health-promoting value-added products from rice derivatives in the Indian market.
In the United States, the FDA regulates the use of food additives and dietary supplements. If Gamma Oryzanol is intended for use in food products or as a dietary supplement, it may fall under the jurisdiction of the FDA, which sets standards for safety, labeling, and claims for such products.
Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Gamma Oryzanol Manufacturers, Suppliers, and Distributors, Raw Material Suppliers, Government Regulatory and Research Organizations, End-Use Industries and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.